Shu Lu

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Randomized Controlled Trial

Spinal Cord Injury

Chemotherapy Induced

Top Venues

Nature cardiovascular research

This page only lists publications with an associated author ORCID identifier.

Publications

Sarajo K Mohanta, Ting Sun, Shu Lu, Zhihua Wang, Xi Zhang, Changjun Yin, Christian Weber, Andreas J R Habenicht
The Impact of the Nervous System on Arteries and the Heart: The Neuroimmune Cardiovascular Circuit Hypothesis. Cells 12 (20) (2023)
Zhihua Wang, Xi Zhang, Shu Lu, Chuankai Zhang, Zhe Ma, Rui Su, Yuanfang Li, Ting Sun, Yutao Li, Mingyang Hong, Xinyi Deng, Mohammad Rafiee Monjezi, Michael Hristov, Sabine Steffens, Donato Santovito, Klaus Dornmair, Klaus Ley, Christian Weber, Sarajo K Mohanta, Andreas J R Habenicht, Changjun Yin
Pairing of single-cell RNA analysis and T cell antigen receptor profiling indicates breakdown of T cell tolerance checkpoints in atherosclerosis. Nature cardiovascular research 2 (3) (2023)
Sarajo K Mohanta, Li Peng, Yuanfang Li, Shu Lu, Ting Sun, Lorenzo Carnevale, Marialuisa Perrotta, Zhe Ma, Benjamin Förstera, Karen Stanic, Chuankai Zhang, Xi Zhang, Piotr Szczepaniak, Mariaelvy Bianchini, Borhan R Saeed, Raimondo Carnevale, Desheng Hu, Ryszard Nosalski, Fabio Pallante, Michael Beer, Donato Santovito, Ali Erturk, Thomas C Mettenleiter, Barbara G Klupp, Remco T A Megens, Sabine Steffens, Jaroslav Pelisek, Hans-Henning Eckstein, Robert Kleemann, Livia Habenicht, Ziad Mallat, Jean-Baptiste Michel, Juergen Bernhagen, Martin Dichgans, Giuseppe D'Agostino, Tomasz J Guzik, Peder S Olofsson, Changjun Yin, Christian Weber, Giuseppe Lembo, Daniela Carnevale, Andreas J R Habenicht
Neuroimmune cardiovascular interfaces control atherosclerosis. Nature 605 (7908) (2022)